Phenotypic and molecular analysis of six human cell lines derived from patients with plasma cell dyscrasia
Cell adhesion molecule CD166 drives malignant progression and osteolytic disease in multiple myeloma
Goat anti-Human Lambda Light Chain Secondary Antibody (NBP1-72788): Novus Biologicals
Response of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1 | Haematologica
Cell adhesion molecule CD166 drives malignant progression and osteolytic disease in multiple myeloma
Detection of a rare BCR–ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS) | PNAS
A) Ultrastructure of NCI-H929 | Download Scientific Diagram
Utility of Intravenous Curcumin Nanodelivery Systems for Improving In Vivo Pharmacokinetics and Anticancer Pharmacodynamics | Molecular Pharmaceutics
A novel human multiple myeloma cell line with genetic abnormality of 1q21 gains only and CKS1B overexpression
miR-221/222-Mediated Inhibition of Autophagy Promotes Dexamethasone Resistance in Multiple Myeloma
miR-221/222-Mediated Inhibition of Autophagy Promotes Dexamethasone Resistance in Multiple Myeloma
Intense Uptake of Liposomal Curcumin by Multiple Myeloma Cell Lines: Comparison to Normal Lymphocytes, Red Blood Cells and Chron
Detection of a rare BCR–ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS) | PNAS
Intense Uptake of Liposomal Curcumin by Multiple Myeloma Cell Lines: Comparison to Normal Lymphocytes, Red Blood Cells and Chron
Detection of a rare BCR-ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS). - Abstract - Europe PMC
Establishment and Characterization of a Human Plasma Cell Myeloma Culture Having a Rearranged Cellular myc Proto-oncogene - ScienceDirect
Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL